IPHA — Innate Pharma SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareAdventurousSmall CapNeutral

Annual balance sheet for Innate Pharma SA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	219	152	120	101	92.5
Net Total Accounts Receivable
Net Total Receivables	5.69	13.9	13.5	31	46.5
Prepaid Expenses
Total Other Current Assets
Total Current Assets	238	173	138	140	148
Net Property, Plant And Equipment	11.7	11.7	10.2	8.54	6.32
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	401	307	267	208	184
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	122	45.5	79.9	41.3	39.6
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Funded Status
Total Liabilities	184	151	160	154	132
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	217	156	107	54.2	51.9
Total Liabilities & Shareholders' Equity	401	307	267	208	184
Total Common Shares Outstanding
Total Preferred Shares Outstanding